Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayJan 09, 2023 1:11 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space

Flora Growth Corp. (NASDAQ: FLGC), a cannabis cultivator and global distributor, is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena. “Much of Flora Growth’s strength lies in its licensed cultivation, extraction and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping the nation emerge from decades of drug war illicit trade into a recognized and regulated market,” a recent article reads. “From its 247 acres of growing fields, the company’s harvests move into a production pipeline…

Continue Reading

MondayJan 09, 2023 12:35 pm

NetworkNewsBreaks – HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) (FSE: HBFA) Issues December 2022 Production Update

HIVE Blockchain Technologies (NASDAQ: HIVE) (TSX.V: HIVE) (FSE: HBFA) today announced production figures from its global bitcoin (“BTC”) operations for the month of December 2022 and the calendar year 2022. The company reportedly produced 213.8 bitcoin in December, plus USD $3.15 million of income from its energy price hedging and grid balancing strategy. Additionally, HIVE produced crypto assets with a value of 4,752 bitcoin (based on daily average price of BTC) in 2022, which is an 18% increase from the prior year. “We are very happy to be producing over 213 bitcoin this month, while also earning over USD $3…

Continue Reading

MondayJan 09, 2023 12:20 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Poised to Potentially Change History

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is enrolling patients in the United States and Europe for its potentially pivotal global clinical trial in humans for its lead drug candidate designed to treat glioblastoma multiforme (“GBM”), a common and one of the most aggressive primary brain cancers. “The drug, Berubicin, is an anthracycline chemotherapy agent that apparently has the unique ability to cross the blood-brain barrier to target tumors directly. The inability of anthracyclines to cross the blood-brain barrier has been identified as a major obstacle in treating aggressive brain tumors such as GBM and creates an opportunity for CNS…

Continue Reading

MondayJan 09, 2023 12:11 pm

NetworkNewsBreaks – AmeriCann Inc. (ACAN) Announces Record Fiscal Year-End and Quarterly Results

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today released financial and operational results for its fiscal year and quarter ending September 2022. “Our focus on cost efficiency has produced some of the strongest adjusted operating EBITDA margins in the industry,” said CFO Ben Barton. “We look forward to investing the cash flow we are generating to further expand operations at the Massachusetts Cannabis Center and to produce even better financial results for shareholders.” To view the full press release, visit https://nnw.fm/YCYFA About AmeriCann Inc. AmeriCann is a cannabis company that develops cultivation,…

Continue Reading

MondayJan 09, 2023 11:56 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announced the incorporation of a new subsidiary to capitalize on drug development incentives in Australia. The company also announced its expanded focus to investigate other products addressing acute medical needs due to substances of abuse such as alcohol, as well as the appointments of Dr. Jeremy Chataway, Dr.Ashwin Dhanda and Dr. Anh Lê to its scientific and clinical expert committee. “We are excited about the incorporation of FSD Pharma Australia, where…

Continue Reading

MondayJan 09, 2023 10:37 am

NetworkNewsBreaks — MetAlert Inc. (MLRT) Featured in Ludlow Research Analyst Brief

MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, spotlighted in a recent Q&A analyst report released by Ludlow Research. In the article, MLRT representations respond to questions, providing an overview of the company and discussing specific topics investors and shareholders might be interested in. The report delved into the company’s recent restructuring, name change and ticker symbol change, with the company stating that “we waited patiently to do this until we had a clean balance sheet and were prepared to take the company to the next level.” The report noted that…

Continue Reading

MondayJan 09, 2023 10:30 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Status Update on Clinical Development Programs

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is discussing upcoming priorities and near-term milestones regarding the status of its two clinical programs aimed at addressing multiple mental health conditions: CYB003 and CYB004. Designed for the treatment of Major Depressive Disorder (“MDD”), CYB003 is currently in a phase 1/2a clinical trial. CYB003 is a deuterated psilocybin analog. CYBN anticipates releasing an interim readout from the trial by the end of February 2023, which will provide an initial understanding of the safety and pharmacokinetic (“PK”) profile of the substance in humans. This interim data will…

Continue Reading

MondayJan 09, 2023 10:10 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Begins New Year by Trading on Upstream

Nutriband (NASDAQ: NTRB), a pioneer in the science of using novel transdermal solutions and other innovative technologies, has kicked off the new by becoming the first NASDAQ company to dual list digital shares on Upstream, a fully regulated global stock exchange for digital securities and NFTs. The company began trading on Upstream yesterday under the ticker symbol NTRB. According to the announcement, the dual listing is designed to provide Nutriband with access to a global, digital-first investor base; potential investors will be able to trade using USDC digital currency as well as credit, debit, PayPal and USD, which will unlock…

Continue Reading

FridayJan 06, 2023 1:47 pm

NetworkNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Eyes Transition of ZVS Prototype from Lab to Real-World Demonstrations

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a company focused on developing transformative power conversion technologies, recently completed its 800-volt, 250-kilowatt Zero Voltage Switching (“ZVS”) traction inverter commercial prototype, advancing from a 10-kilowatt technical proof of concept in just one year. “Hillcrest’s ZVS or soft switching capabilities will seek to overcome challenges habitually found in hard-switched wide-bandgap devices such as silicon carbide (‘SiC’) traction inverters. Through the material elimination of switching losses, Hillcrest’s inverter technology has been shown to reduce the thermal management needed across the entire powertrain system. This, in turn, can result in substantial savings in the manufacturing process, reducing…

Continue Reading

FridayJan 06, 2023 1:31 pm

NetworkNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Changing How Commercial Real Estate Owners Optimize Energy Assets

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is helping to advance progress on the greenhouse gas reduction front. “The company is making it easier and cost effective for those in the commercial real estate industry to acquire the necessary solutions for solar, cogeneration, energy storage, and electric vehicle infrastructure, as well as driving intelligent efficiency retrofits for community-scale applications… Correlate provides proprietary analytics and advisement for companies seeking to reduce the carbon footprint of their buildings before helping clients navigate the tricky journey toward managing and financing infrastructure…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000